S100A12 and depressive symptom measurement: Consistent with this study, S100A12 is reported to be most clinically diagnosable biomarker upregulated in depression based on machine learning algorithms (57), whereas, which was found upregulated in blood and downregulated in tissues of IPF patients (63).